Robert Lee Hines

US Patent:

6465473, Oct 15, 2002

Filed:

Feb 22, 2000

Appl. No.:

09/510704

Inventors:

Robert Hines - Fayetteville NC 28304

International Classification:

A61K 3152

US Classification:

514262, 514356, 514398, 514561

Abstract:

An improved method for treatment of conditions in human beings associated with either or both reactive arthritis or bursitis comprising administration of a combination of L-lysine, minocycline hydrochloride, metronidazole, and valacyclovir hydrochloride. A first alternate method comprises administration of L-lysine, minocycline hydrochloride, and metronidazole. A second alternate method comprises administration of L-lysine, minocycline hydrochloride, metronidazole, and isonicotinic acid hydrazide.

US Patent:

6765000, Jul 20, 2004

Filed:

Oct 15, 2002

Appl. No.:

10/271117

Inventors:

Robert Hines - Fayetteville NC 28304

International Classification:

A61K 3165

US Classification:

514152, 514154, 5142621, 514398

Abstract:

A treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising a combination of acyclovir, minocycline hydrochloride, and metronidazole. An alternate treatment comprises the combination of valacyclovir hydrochloride, minocycline hydrochloride, and metronidazole.

US Patent:

7053073, May 30, 2006

Filed:

Jul 20, 2004

Appl. No.:

10/896612

Inventors:

Robert Hines - Fayetteville NC, US

Assignee:

Ficaar, Inc. - Alameda CA

International Classification:

A61K 31/65
A61K 31/519
A61K 31/415

US Classification:

514152, 514154, 5142621, 514398

Abstract:

A treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising a combination of valacyclovir hydrochloride, minocycline hydrochloride, and metronidazole.

US Patent:

7691831, Apr 6, 2010

Filed:

Mar 29, 2005

Appl. No.:

11/096260

Inventors:

Robert Hines - Fayetteville NC, US

International Classification:

A61K 31/65
A61K 31/519

US Classification:

514152, 514154, 5142621, 514398

Abstract:

A method for treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising administering a combination of a member from each of the following groups of medications: (1) synthetic purine nucleoside analog antiviral drugs, (2) antibiotic drugs, and (3) imidazole drugs. Alternate embodiments of the invention include dual combinations of (A) a member of the synthetic purine nucleoside analog group of antiviral drugs and a member of the antibiotic group of drugs, (B) a member of the antibiotic group of drugs and a member of the imidazole family of drugs, and (C) a member of the synthetic purine nucleoside analog group of antiviral drugs and a member of the imidazole group of drugs.

US Patent:

7884090, Feb 8, 2011

Filed:

Dec 7, 2005

Appl. No.:

11/296575

Inventors:

Robert Hines - Fayetteville NC, US

International Classification:

A61K 31/65
A61K 31/519
A61K 31/44
A61K 31/42
A61K 31/195

US Classification:

514152, 5142621, 514356, 514398, 514561

Abstract:

The present invention provides compositions, combination of medicaments, and methods for the treatment of certain conditions such as arthritis, and in particular, reactive arthritis, osteoarthritis, and bursitis, among others.

US Patent:

20020094988, Jul 18, 2002

Filed:

Jan 4, 2002

Appl. No.:

10/039993

Inventors:

Robert Hines - Fayetteville NC, US
Ernest Bonner - Alameda CA, US

International Classification:

A61K031/496
A61K031/47

US Classification:

514/252160, 514/307000

Abstract:

An improved method of treating male erectile dysfunction by enteral administration of a combination of sildenafil citrate and papavarine hydrochloride. An alternate mode of treatment indicated for individuals with known vascular disease includes the contemporaneous administration of pentoxifylline. Further embodiments include administration of zinc monomethionine aspartate.

US Patent:

20050137181, Jun 23, 2005

Filed:

Feb 9, 2005

Appl. No.:

11/054921

Inventors:

Ernest Bonner - Hillsborough CA, US
Robert Hines - Fayetteville NC, US

International Classification:

A61K031/65
A61K031/522
A61K031/4172

US Classification:

514192000, 514263320, 514400000

Abstract:

A method for treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the tetracycline family, and a member of the nitroimidazole family, or alternatively, administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the beta-lactam family, and a member of the nitroimidazole family, or alternatively, administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the macrolide antimicrobial family, and a member of the nitroimidazole family, or alternatively, administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the ketolide antimicrobial family, and a member of the nitroimidazole family.

US Patent:

20050176690, Aug 11, 2005

Filed:

Feb 4, 2005

Appl. No.:

11/051171

Inventors:

Ernest Bonner - Hillsborough CA, US
Robert Hines - Fayetteville NC, US

International Classification:

A61K031/65
A61K031/522
A61K031/52
A61K031/4164

US Classification:

514154000, 514263310, 514263400, 514398000

Abstract:

A method for treatment for conditions in human beings associated with either or both reactive arthritis or bursitis comprising administering a combination of member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the tetracycline family, and a member of the nitroimidazole family, or alternatively, administering a combination of a member of the family of synthetic purine nucleoside analog antiviral drugs, a member of the quinolone family, and a member of the nitroimidazole family.